Dogwood Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 3.13 M | $5.04 M | -4.50% | 9.18% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 341.81 K | $550.32 K | 100.00% | 1.00% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 132.15 K | $212.77 K | 0.00% | 0.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 88.30 K | $142.16 K | 11.16% | 0.26% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 62.74 K | $101.01 K | 0.00% | 0.18% |
| BLACKROCK, INC. | 08/07/2026 | 28.55 K | $45.96 K | 95,053.33% | 0.08% |
| NORTHERN TRUST CORP | 08/13/2026 | 23.78 K | $38.28 K | 0.00% | 0.07% |
| CITADEL ADVISORS LLC | 09/02/2026 | 11.74 K | $18.91 K | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 3.09 K | $4.98 K | -61.66% | 0.01% |
| MORGAN STANLEY | 08/13/2026 | 2.22 K | $3.58 K | 100.00% | 0.01% |
| UBS GROUP AG | 08/13/2026 | 1.86 K | $3.00 K | -73.75% | 0.01% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 550 | $886 | 100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 160 | $264 | 100.00% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 157 | $253 | 100.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 07/16/2026 | 120 | $193 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 9 | $14 | 0.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dogwood Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 20 institutional investors and hedge funds held shares of Dogwood Therapeutics Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 3.13 M
MILLENNIUM MANAGEMENT LLC: 341,814
VANGUARD CAPITAL MANAGEMENT LLC: 132,154
GEODE CAPITAL MANAGEMENT, LLC: 88,298
VANGUARD FIDUCIARY TRUST CO: 62,736
BlackRock, Inc.: 28,546
11.22% of Dogwood Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.86 M shares in the last 24 months. This purchase volume represents approximately $11.81 M in transactions.